Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome
- 1 May 2002
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 61 (5) , 1801-1805
- https://doi.org/10.1046/j.1523-1755.2002.00303.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndromePediatric Nephrology, 2001
- C2 Monitoring Strategy for Optimising Cyclosporin Immunosuppression from the Neoral??* FormulationBioDrugs, 2001
- Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndromePediatric Nephrology, 1999
- Treatment of the nephrotic syndrome associated with primary glomerulonephritisKidney International, 1994
- Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhoodEuropean Journal of Pediatrics, 1992
- Risk Factors for Cyclosporine-Induced Nephropathy in Patients with Autoimmune DiseasesNew England Journal of Medicine, 1992
- Cyclosporine A induced remission of relapsing nephrotic syndrome in childrenKidney International, 1988
- Early identification of frequent relapsers among children with minimal change nephrotic syndrome: A report of the International Study of Kidney Disease in ChildrenThe Journal of Pediatrics, 1982
- Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularityKidney International, 1981
- PATHOLOGY OF THE NEPHROTIC SYNDROME IN CHILDRENThe Lancet, 1970